B. Christopher

Metabolomic Profiling Reveals Distinct Patterns of Myocardial Substrate Use in Humans With Coronary Artery Disease or Left Ventricular Dysfunction During Surgical Ischemia/Reperfusion

D. Glower, J. Mathew, M. Podgoreanu, 2009, Circulation.

Lipoprotein-Associated Phospholipase A 2 Activity Is a Marker of Risk But Not a Useful Target for Treatment in Patients With Stable Coronary Heart Disease

Weiss, C. Held, P. Armstrong, 2016 .

High Sensitivity Troponin I for Risk Assessment in Patients with Atrial Fibrillation: Insights from the ARISTOTLE Trial

D. Atar, B. Gersh, E. Hylek, 2013 .

Title: Analysing recurrent hospitalisations in heart failure: a review of statistical methodology, with application to CHARM-Preserved Short Title: Rogers et al, Analysing recurrent hospitalisations

M. Pfeffer, S. Yusuf, K. Swedberg, 2015 .

a repository of Intra-cardiac and peripheral levels of biochemical markers of fibrosis in patients undergoing catheter ablation for atrial fibrillation .

A. Holden, K. Rhode, R. Karim, 2018 .

Diastolic dysfunction in people with HIV without known cardiovascular risk factors in Western Kenya

G. Bloomfield, W. Post, S. Ndege, 2022, Open Heart.